Adaptilens fetches $1.6m seed

Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this